President-Biotechnology Lupin Limited
COVER STORY
DR CYRUS KARKARIA
President-Biotechnology Lupin Limited
Dr Cyrus Karkaria leads Lupin ' s biotechnology division and is responsible for developing the company ' s global biosimilars portfolio. With over three decades of experience at Celldex Therapeutics, CuraGen and Biogen, Cyrus has a proven track record in managing biologic drug development and commercialization of products across multiple markets, including the U. S. Cyrus is a postdoctorate from Harvard Medical School and a Ph. D. from the University of Maryland.
24
BioVoiceNews | April 2025